Stratec SE (ETR:SBS)
22.05
-0.25 (-1.12%)
Jan 8, 2026, 5:41 PM CET
Stratec SE Revenue
Stratec SE had revenue of 57.00M EUR in the quarter ending September 30, 2025, a decrease of -5.42%. This brings the company's revenue in the last twelve months to 260.25M, up 1.78% year-over-year. In the year 2024, Stratec SE had annual revenue of 257.62M, down -4.73%.
Revenue (ttm)
260.25M
Revenue Growth
+1.78%
P/S Ratio
1.04
Revenue / Employee
183.28K
Employees
1,387
Market Cap
271.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.62M | -12.79M | -4.73% |
| Dec 31, 2023 | 270.41M | -4.21M | -1.53% |
| Dec 31, 2022 | 274.63M | -12.71M | -4.42% |
| Dec 31, 2021 | 287.34M | 37.24M | 14.89% |
| Dec 31, 2020 | 250.10M | 35.94M | 16.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Stratec SE News
- 7 weeks ago - Stratec SE (STSEY) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Supply Chain ... - GuruFocus
- 7 weeks ago - Q3 2025 Stratec Se Earnings Call Transcript - GuruFocus
- 2 months ago - STRATEC Unveils Key 2025 Results for First Nine Months - Wallstreet:Online
- 2 months ago - EQS-News: STRATEC REPORTS DEFINITIVE RESULTS FOR FIRST NINE MONTHS OF 2025 - Wallstreet:Online
- 2 months ago - Stratec Lowers FY25 Sales Outlook Due To Interruptions In Supply Of Input Materials - Nasdaq
- 2 months ago - STRATEC Faces Delays: 2025 Sales Guidance Adjusted Amid Supply Issues - Wallstreet:Online
- 2 months ago - EQS-Adhoc: STRATEC REPORTS SUPPLY CHAIN-RELATED PRODUCTION DELAYS, ADJUSTMENT TO 2025 SALES GUIDANCE AND PRELIMINARY RESULTS FOR 9M/2025 - Wallstreet:Online
- 4 months ago - EQS-News: STRATEC ENLARGES ITS BOARD OF MANAGEMENT - Wallstreet:Online